Organisation paid for research Program year 2020 Source: CMS Open Payments

Tennessee Oncology Admin

Neither a doctor nor a teaching hospital

Research payments

$3,023,601

396 payments

Through program year 2020, Tennessee Oncology Admin is reported as receiving $3,023,601 in research payments, across 396 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$868,140	258
2019	Research	$2,155,461	138

Breakdown

Who paid Research payments · program years 2019–2020

Boehringer Ingelheim International GmbH $2,999,254 355 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $13,997 5 payments
Daiichi Sankyo Inc. $10,349 36 payments

Studies the money was for Research payments · program years 2019–2020

BI754111 & BI754091/BI75411 combination $1,943,021 164 payments
BI 754091 first-in-man dose escalation $538,917 145 payments
PD1 longitudinal study $346,538 4 payments
PD1 + longitudinal study $170,778 42 payments
U31402-A-U102 $10,349 36 payments
Phase I BI907828 in advance TP53WT MDM2 amplified $6,074 2 payments
BI754111 & BI754091 BI75411 combination $4,834 1 payment
BI 754091 first in man dose escalation $3,088 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.